SCHEMBL21362390

SCHEMBL21362390

CCc1ccc(C(=O)c2cc(OC)ccc2B2OC(C)(C)C(C)(C)O2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.50
MAPT P10636 4/20 0.46
HTT P42858 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
GAA P10253 1/20 0.44
ALDH1A1 P00352 2/20 0.42
HIF1A Q16665 1/20 0.42
NPC1 O15118 1/20 0.42
CYP2C9 P11712 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
POLB P06746 3/20 0.41
LMNA P02545 1/20 0.41
SLC22A12 Q96S37 5/20 0.40
BLM P54132 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157598 0.87 MAPT (0.52) UCHL1MAPTHTTNPSR1ALDH1A1
SCHEMBL18125724 0.86 POLB (0.59) UCHL1MAPTHTTNPSR1GAA
SCHEMBL20157840 0.86 HTT (0.48) UCHL1MAPTHTTNPSR1GAA
SCHEMBL29582110 0.86 POLB (0.59) UCHL1MAPTHTTNPSR1GAA
SCHEMBL20157902 0.81 CXCR2 (0.41) UCHL1MAPTGAAALDH1A1LMNA
SCHEMBL29853895 0.80 KDM4E (0.49) UCHL1MAPTHTTNPSR1GAA
SCHEMBL19946115 0.80 KDM4E (0.49) UCHL1MAPTHTTNPSR1GAA
SCHEMBL29272831 0.79 SMN1; SMN2 (0.48) UCHL1MAPTGAAALDH1A1NPC1
SCHEMBL20157806 0.77 HTT (0.49) UCHL1MAPTHTTNPSR1GAA
SCHEMBL20157615 0.77 UCHL1 (0.48) UCHL1MAPTHTTNPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed